在冠状动脉旁路手术后冠状动脉再干预的病因学
Ikram Achbar1, De Qing F N Görtzen1, Joost F J Ter Woorst1
1Department of Cardiothoracic Surgery, Catharina Hospital, 5623 EJ Eindhoven, The Netherlands.
Journal of cardiovascular development and disease
|January 27, 2026
概括
在冠状动脉旁路移植 (CABG) 后,8.7%的患者出现了冠状动脉再干预,主要是由于移植失败. 风险因素包括糖尿病和单个动脉移植,整体存活率没有显著差异.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 冠状动脉旁路移植 (CABG) 是冠状动脉疾病的标准治疗方法.
- 虽然CABG与皮肤冠状动脉干预 (PCI) 相比降低了再血管化的风险,但随后的冠状动脉再干预仍然可能发生.
- 了解CABG后重新干预的发生率和原因对于患者管理至关重要.
研究的目的:
- 评估隔离CABG后冠状动脉再干预的发生率.
- 确定驱动这些重新干预的主要病因.
- 确定与需要重新干预相关的风险因素.
主要方法:
- 一项回顾性队列研究分析了4814名在2016年1月至2021年12月期间接受隔离CABG的患者.
- 在2022年12月之前,通过机构记录,荷兰心脏注册 (NHR) 和图表审查收集了手术或皮肤穿刺再干预的数据.
- 进行了多变量分析,以确定重新干预的独立风险因素.
主要成果:
- 8.7%的患者 (n=418) 在平均4.5年的随访期间需要冠状动脉再干预.
- 移植失败 (64.6%) 是主要原因,其次是冠状动脉疾病的进展 (20.3%) 和不完全的再血管化 (10.5%).
- 重新干预的独立风险因素包括糖尿病,使用单个动脉移植和长时间通风 (>24小时).
结论:
- 在CABG后的显著少数患者中,冠状动脉再干预是必要的,移植失败是主要的驱动因素.
- 识别患有更高风险的患者,如糖尿病患者或特定移植配置的患者,可以为预防策略提供信息.
- 接受再干预的患者和没有接受再干预的患者之间的中期生存率是可比的.
相关概念视频
01:30Coronary Artery Disease I: Introduction
1.0K
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.0K
01:26Coronary Artery Disease II: Pathophysiology
415
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
415
01:27Coronary Artery Disease V: Interprofessional Care
246
Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
246
01:21Coronary Circulation
7.1K
The heart, an organ critical to survival, gets nourishment not from the blood it pumps but from a separate circulation system known as coronary circulation. This is the shortest circulation in the body and is responsible for supplying the heart with the nutrients it needs to function effectively.
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
Coronary circulation begins at the base of the aorta, where two main arteries arise—the left and right coronary arteries. These arteries encircle the heart in the coronary sulcus and supply the...
7.1K
01:30Coronary Artery Disease III: Clinical Manifestations
359
Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
359
01:26Coronary Artery Disease IV: Preventive Measures
658
Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
658